CBT
IBB icon

CoreFirst Bank & Trust’s iShares Biotechnology ETF IBB Stock Holding History

CoreFirst Bank & Trust’s Portfolio IBB Stock Details IBB Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2023
Q4 		– Sell
-234
Closed -$28.6K – 383
2023
Q3 		$28.6K Hold
234
– – 0.02% 272
2023
Q2 		$29.7K Buy
+234
New +$30.4K 0.02% 255

Other funds holding IBB

Bank of America
Bank of America Charlotte, North Carolina $1.37T AUM 24.88% 1-Year Est. Return
Morgan Stanley
Morgan Stanley New York $1.66T AUM 25.57% 1-Year Est. Return
Citigroup
Citigroup New York $235B AUM 32.99% 1-Year Est. Return
Goldman Sachs
Goldman Sachs New York $871B AUM 31.28% 1-Year Est. Return
JP Morgan Chase
JP Morgan Chase New York $1.56T AUM 27.86% 1-Year Est. Return
BNP Paribas Financial Markets
BNP Paribas Financial Markets Paris, France $206B AUM 31.61% 1-Year Est. Return
UBS Group
UBS Group Zurich, Switzerland $666B AUM 30.12% 1-Year Est. Return
Royal Bank of Canada
Royal Bank of Canada Toronto, Ontario, Canada $570B AUM 27.57% 1-Year Est. Return
CB
Commerce Bank Kansas City, Missouri $20.7B AUM 23.76% 1-Year Est. Return
Wells Fargo
Wells Fargo San Francisco, California $530B AUM 22.01% 1-Year Est. Return

CoreFirst Bank & Trust's IBB Position: Q4 2023 in Review

CoreFirst Bank & Trust sold out of iShares Biotechnology ETF (IBB) in Q4 2023, closing a stake of 234 shares — an estimated $28.6K sold.

CoreFirst Bank & Trust first reported a position in IBB in Q2 2023 and held it in 2 quarters. The position peaked at $29.7K in Q2 2023. 872 funds tracked by Wall St. Rank hold IBB as of Q4 2023.

  • CoreFirst Bank & Trust reported no remaining iShares Biotechnology ETF position as of Q4 2023 after selling out during the quarter.
  • CoreFirst Bank & Trust sold 234 iShares Biotechnology ETF shares in Q4 2023, an estimated $28.6K.
  • CoreFirst Bank & Trust first reported a position in iShares Biotechnology ETF in Q2 2023 and held it in 2 quarters.
  • CoreFirst Bank & Trust's iShares Biotechnology ETF position peaked at $29.7K in Q2 2023.
  • 872 funds tracked by Wall St. Rank held iShares Biotechnology ETF as of Q4 2023.

Based on CoreFirst Bank & Trust's 13F filing for Q4 2023, filed 18 Mar 2024.